Daniel Refai, MD
-
RoleNeurosurgery, Spine Surgery
-
Specialty
-
Research Program
-
Practicing Since2009
Background
Daniel Refai is the director of spinal oncology at the Emory Spine Center. Dr. Refai focuses on both intradural and extradural spinal tumors as well as metastatic and primary tumors of the spine. He performs complex spine tumor surgery and spine reconstruction surgery. He also directs the stereotactic radiosurgery division of the Emory Spine Center for spine tumor treatment. Dr. Refai's research interests include outcome analysis following surgery and radiosurgery for spine tumors. He has published extensively on the treatment of spinal disorders and has developed innovative multidisciplinary approaches for treatment. He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, and the North American Spine Society.
Dr. Refai completed neurosurgical residency at Washington University in Saint Louis under the tutelage of Ralph Dacey MD. He spent six months as a specialist registrar in neurosurgery at Beaumont Hospital in Dublin, Ireland. He completed a combined orthopaedic and neurosurgery spine fellowship at the Cleveland Clinic under Edward Benzel MD, Iain Kalfas MD, Gordon Bell MD, and others. He specializes in all aspects of complex spine surgery and is actively involved in clinical research. Dr. Refai enjoys teaching and has received numerous patient and medical education distinctions throughout his training.
Titles & Roles
-
Professor, Department of NeurosurgeryEmory University School of Medicine
-
Professor, Department of OrthopaedicsEmory University School of Medicine
-
Director of Spinal OncologyEmory Spine Center
Education & Training
Education
- Residency, Neurosurgery, 2009Barnes - Jewish Hospital
- Internship, Neurosurgery, 2004Barnes - Jewish Hospital
- Medical Education, MD, 2003University of Chicago
Board Certifications
- Neurological SurgeryAmerican Board of Neurological Surgery, 2013
Research
Grants
Grant Number Title Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.8 Provider showed concern 4.8 Provider explained things clearly 4.8 Provider discussed treatment options 4.8 Provider included you in decisions 4.8 Likelihood of recommending this provider